News

Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted

FlareHawk Expandable Lumbar Interbody Fusion System Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices ImplantedPALM…

2 years ago

Cannabix Technologies to Participate in October Southern US Study using Marijuana Breathalyzer Technology

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety Cannabix October…

2 years ago

SCYNEXIS to Present Positive Interim Data from the Phase 3 FURI Study of Oral Ibrexafungerp at IDWeek 2022

JERSEY CITY, N.J., Oct. 11, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to…

2 years ago

Tarsus Announces Transition Plans for Board of Directors

Co-founder and Chairman Michael Ackermann plans to transition off Board of Directors Wendy Yarno will become Lead Independent Director and…

2 years ago

Surgalign™ Awarded 2022 Best New Technology Award from Orthopedics This Week for its HOLO Portal™ Surgical Guidance System

World’s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgery recognized by panel of leading orthopedic surgeonsDEERFIELD,…

2 years ago

SELLAS Life Sciences’ Licensee, 3D Medicines, Doses First Patient in Phase 1 Clinical Trial in China of Galinpepimut-S

NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a…

2 years ago

Brooklyn ImmunoTherapeutics Announces Name Change to Eterna Therapeutics and Provides Corporate Updates

New name reflects Company focus on leveraging exclusively in-licensed foundational mRNA cell engineering patent portfolio The Eterna corporate mission is…

2 years ago

Odyssey Health, Inc. Forms Pharmaceutical Subsidiary Focused on Treating Neurological Diseases

Las Vegas, Nevada, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a…

2 years ago

Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022

MARLBOROUGH, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…

2 years ago